15.1 Self‐injury |
1 |
|
Std. Mean Difference (IV, Random, 95% CI) |
Subtotals only |
15.2 Adverse effects: musculoskeletal |
1 |
|
Risk Ratio (IV, Random, 95% CI) |
Subtotals only |
15.2.1 Dystonia |
1 |
23 |
Risk Ratio (IV, Random, 95% CI) |
2.36 [0.11, 52.41] |
15.3 Adverse effects: neurological |
1 |
|
Risk Ratio (IV, Random, 95% CI) |
Subtotals only |
15.3.2 Fatigue/lethargy |
1 |
23 |
Risk Ratio (IV, Random, 95% CI) |
8.64 [0.53, 140.05] |
15.4 Adverse effects: psychological |
1 |
|
Risk Ratio (IV, Random, 95% CI) |
Subtotals only |
15.4.1 Behaviour problems |
1 |
23 |
Risk Ratio (IV, Random, 95% CI) |
0.34 [0.16, 0.73] |
15.5 Tolerability/acceptabiity: loss to follow‐up |
2 |
40 |
Risk Ratio (IV, Random, 95% CI) |
0.46 [0.14, 1.49] |